Cart
sales@molnova.com
PAP-1
CAS No. 870653-45-5
PAP-1( 5-(4-Phenoxybutoxy)psoralen )
Catalog No. M24882 CAS No. 870653-45-5
PAP-1 is a selective, and orally active Kv1.3 blocker (EC50: 2 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 87 | In Stock |
|
| 2MG | 54 | In Stock |
|
| 5MG | 77 | In Stock |
|
| 10MG | 131 | In Stock |
|
| 25MG | 292 | In Stock |
|
| 50MG | 509 | In Stock |
|
| 100MG | 538 | In Stock |
|
| 200MG | 769 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePAP-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPAP-1 is a selective, and orally active Kv1.3 blocker (EC50: 2 nM).
-
DescriptionPAP-1 is a selective, and orally active Kv1.3 blocker (EC50: 2 nM).
-
In VitroPAP-1 (2-100 nM; 30 minutes) suppresses the proliferation of CCR7-TEM cells with IC50 of 10 nM. Cell Proliferation Assay Cell Line:CCR7-TEM cells (anti-CD3 Ab stimulated)Concentration:2, 10, 25, 100 nM Incubation Time:30 minutes Result:Suppresses the Proliferation of CCR7-TEM cells with IC50 of 10 nM.
-
In VivoPAP-1 (0.3-3 mg/kg; i.p.; three times daily for 48 hours) prevents delayed type hypersensitivity (DTH) in lewis rats. Animal Model:9- to 11- week-old female Lewis rats Dosage:Intraperitoneal injection; three times daily for 48 hours Administration:0.3, 1, 3 mg/kg Result:Dose-dependently suppressed the DTH reaction.
-
Synonyms5-(4-Phenoxybutoxy)psoralen
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorKv1.3 channels
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number870653-45-5
-
Formula Weight350.36
-
Molecular FormulaC21H18O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:48 mg/mL (137 mM; Need ultrasonic);Water:Insoluble
-
SMILESO=C(C=C1)Oc2c1c(OCCCCOc1ccccc1)c(cco1)c1c2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Senicapoc
A potent, selective Gardos channel blocker that blocks Ca(2+)-induced rubidium flux from human RBCs (IC50=11 nM) and inhibits RBC dehydration (IC50=10-50 nM).
-
Aprikalim
Aprikalim (RP 52891) is an adenosine triphosphate potassium channel (KATP) opener that protects against nerve damage in a rabbit model of spinal cord ischemia.Aprikalim inhibits vasoconstriction and inhibits the elevation of [Ca2+]i during myocardial paralysis, and can be used to study cardiovascular disease.
-
Lei-Dab 7
High affinity, selective KCa2.2 (SK2) channel blocker (Kd = 3.8 nM). Exhibits >200-fold selectivity for KCa2.2 over KCa2.1, KCa2.3, KCa3.1, IK, Kv and Kir2.1. Increases theta-burst responses and increases LTP in rat hippocampal slices in vitro. Convulsive in vivo.
